4//SEC Filing
Kapadia Sandip 4
Accession 0001415889-25-002158
CIK 0001802665other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 4:04 PM ET
Size
16.0 KB
Accession
0001415889-25-002158
Insider Transaction Report
Form 4
Kapadia Sandip
CHIEF FINANCIAL OFFICER
Transactions
- Sale
Common Stock
2025-01-27$38.05/sh−1,775$67,547→ 0 total - Award
Stock Option
2025-01-25+66,250→ 66,250 totalExercise: $38.01Exp: 2035-01-25→ Common Stock (66,250 underlying) - Award
Restricted Stock Units
2025-01-25+18,900→ 18,900 total→ Common Stock (18,900 underlying) - Exercise/Conversion
Common Stock
2025-01-24+3,812→ 3,812 total - Exercise/Conversion
Restricted Stock Units
2025-01-24−3,812→ 11,438 total→ Common Stock (3,812 underlying) - Tax Payment
Common Stock
2025-01-24$38.01/sh−2,037$77,426→ 1,775 total
Footnotes (6)
- [F1]Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.80 to $38.68. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.
- [F5]The stock option vests with respect to 25% of the underlying shares on January 25, 2026, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.
- [F6]. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.
Documents
Issuer
Harmony Biosciences Holdings, Inc.
CIK 0001802665
Entity typeother
Related Parties
1- filerCIK 0001677141
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 4:04 PM ET
- Size
- 16.0 KB